Delivra Health Brands Launches LivRelief (TM) Itch Relief Cream in the Canadian Market
Vancouver, British Columbia--(Newsfile Corp. - July 2, 2026) - Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF) ("Delivra Health" or the "Company"), a consumer packaged goods company uniquely positioned in the health and wellness sector, is pleased to announce that its LivReliefTM brand is launching its new Itch Relief Cream in the Canadian market. The LivRelief TM Itch Relief Cream is available to Company distributors, retailers and e-commer
Cannabis, Santé, Extracteurs de cannabis, Producteurs de cannabis
2026-07-02 7:30 AM EDT | Delivra Health Brands Inc.
Altrova Health Announces Board and Chairman Transition
Toronto, Ontario--(Newsfile Corp. - July 2, 2026) - Altrova Health Inc. (CSE: ROVA) (OTCQB: SSPLF) (FSE: WF8) (the "Company" or "Altrova Health") today announced a transition in its Board of Directors leadership. Raf Souccar has resigned as Chairman and as a member of the Company's Board of Directors. The Company is grateful for Mr. Souccar's service and is pleased that he will continue to support Altrova Health in an advisory capacity going forward. The Board has appointe
2026-07-02 7:06 AM EDT | Altrova Health Inc.
Restart Life Sciences Reports Record-Breaking June Revenue for Holy Crap Foods as Amazon Canada Sales Surge YoY
Vancouver, British Columbia--(Newsfile Corp. - July 2, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to report its preliminary, unaudited financial results for the month of June 2026 regarding its wholly owned subsidiary, Holy Crap Foods Inc., alongside an update on internal operational infrastructure and market expansion initiatives. Following the acquisition of Holy Crap Foods Inc. on February 27, 2026, the C
2026-07-02 6:00 AM EDT | Restart Life Sciences Corp.
Invitation to Cosmo's Half-Year 2026 Financial Results Webcast on 23 July 2026
Dublin, Ireland--(Newsfile Corp. - July 1, 2026) - Cosmo N.V. (SIX: COPN) (“Cosmo”) announced today that it will publish its Half-Year 2026 results on Thursday, 23 July 2026 at 7:00 am CEST. Live conference call and audio webcast presentation: Cosmo invites investors, financial analysts and business/life sciences journalists to a live webcast presentation which will follow on the same day at 3:00 pm CEST. Gio
Soins de santé et hôpitaux, Santé
2026-07-01 1:00 AM EDT | Cosmo Pharmaceuticals N.V.
Adia Med Finds Another Unicorn
Winter Park, Florida--(Newsfile Corp. - June 30, 2026) - Adia Med Inc. (OTCQB: ADIA), a regenerative medicine and stem cell therapies company, today announced that CEO Larry Powalisz recently sat down for a podcast interview with Dr. Lyday, a physician recognized as a champion for stem cell-based treatments.
Soins de santé et hôpitaux, Santé
2026-06-30 12:49 PM EDT | Adia Med Inc.
Marquis Health Consulting Services Marks America's 250th Anniversary with 'Home, anew,' a Tribute to Senior Stories of Belonging, Resilience and Community
Brick Township, New Jersey--(Newsfile Corp. - June 30, 2026) - In conjunction with America's historic semiquincentennial anniversary, the Marquis Health Consulting Services Senior Living team has proudly published 'Home, anew: 250 Voices of Belonging and Community, Celebrating Our Nation's 250th Year.' The commemorative book features over 250 stories and reflections from residents, family and team members across the senior living
Soins de santé et hôpitaux, Santé
2026-06-30 12:31 PM EDT | Marquis Health Consulting Services
CBD of Denver, Inc. (CBDD) Advances Evaluation of AI-Driven Health & Wellness Acquisition Opportunity
Denver, Colorado--(Newsfile Corp. - June 30, 2026) - CBD of Denver, Inc. (OTCID: CBDD) ("CBDD" or the "Company") today announced that it has entered the due diligence phase with respect to a prospective acquisition in the health and wellness sector. As part of the Company's ongoing acquisition plans, management has reviewed a number of businesses spanning artificial intelligence, technology, consumer products, and health and wellness. Through this process, the Company identified an oper
Cannabis, Santé, Extracteurs de cannabis, Producteurs de cannabis
2026-06-30 9:46 AM EDT | CBD of Denver Inc.
Apptly's UberDoc Accelerates Growth Through Emphera Health Partnership, Adding Approximately 2,000 Specialists to the UberDoc Network
Vancouver, British Columbia--(Newsfile Corp. - June 30, 2026) - Apptly Health Technologies Corp. (CSE: APPT) (FSE: 4KL0) (the "Company"), operator of the UberDoc direct-pay healthcare marketplace ("UberDoc"), today announced that it has entered into a Strategic Collaboration Agreement with Emphera Health Holdings, Inc. dba Emphera Health ("Emphera Health"), a network that connects self-funded employers to outpatient surgical care, for an initial three year term, effective
2026-06-30 8:00 AM EDT | Apptly Health Technologies Corp.
TempraMed Expands Strategic Partnership with McKesson Medical-Surgical to Accelerate North American Growth and Launch Full Portfolio Across B2B Channels
Toronto, Ontario--(Newsfile Corp. - June 30, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE: 9DY) ("TempraMed" or the "Company"), a leader in temperature-controlled medication solutions, is pleased to announce the expansion of its relationship with McKesson Medical-Surgical ("MMS"). The agreement, dated June 23, 2026, broadens the scope of collaboration to include full portfolio distribution across North America, enhanced B2B capabilities, and deeper integration into one of the la
Technologies, Biotechnologies, Pharmaceutique, Santé
2026-06-30 3:05 AM EDT | TempraMed Technologies Ltd.
Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2026 and Provides Conference Call Information
Northvale, New Jersey--(Newsfile Corp. - June 29, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products, announced results for the fiscal year ended March 31, 2026 ("Fiscal 2026"). Consolidated revenues for Fiscal 2026 were $148.9 million, an increase of $64.8 million or approximately 77% as compared to the comparable period of the prior fiscal year. Income from operations was $49.1 million
Soins de santé et hôpitaux, Pharmaceutique, Santé
2026-06-29 4:29 PM EDT | Elite Pharmaceuticals, Inc.
BUNCHIES Named Official Snack of The UNDERRATED Golf Tour
Los Angeles, California--(Newsfile Corp. - June 29, 2026) - BUNCHIES, the golf snack from Hally Leadbetter, today announces a new partnership with UNDERRATED Golf, the purpose-driven junior golf tour founded by four-time NBA Champion, two-time MVP and Olympic gold medalist Stephen Curry. BUNCHIES will serve
Aliments / boissons, Sports, Santé
2026-06-29 10:44 AM EDT | Bunchies
Beckett's Announces Resignation of CEO and Appointment of Interim CEO
Ontario and Los Angeles, California--(Newsfile Corp. - June 29, 2026) - Beckett's Inc. (CSE: BKTS) ("Beckett's" or the "Company") announces that Larry Weintraub has resigned as Chief Executive Officer and as a director of the Company, effective immediately. The Company has appointed Manish Z. Kshatriya, the Company's current Chief Financial Officer, as Interim Chief Executive Officer. Mr. Kshatriya will continue to serve as Chief Financial Officer. In connection w
Aliments / boissons, Cannabis, Santé
2026-06-29 8:22 AM EDT | Becketts Inc.
TempraMed Signs Non-Binding LOI with National Distributor in Saudi Arabia
Toronto, Ontario--(Newsfile Corp. - June 26, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE: 9DY) ("TempraMed" or the "Company"), a medical-technology innovator transforming how temperature-sensitive medications are stored and managed, is pleased to announce that it has signed a non-binding letter of intent ("LOI") dated June 16, 2026 with Rawafed Health International Company ("Rawafed"), a leading healthcare distribution company with broad reach across pharmacy networks a
Technologies, Biotechnologies, Pharmaceutique, Santé
2026-06-26 4:10 PM EDT | TempraMed Technologies Ltd.
ScaleHealth.ca Launches Turnkey Recovery Layer for Health & Wellness Brands, Starting with DR-HO's
Toronto, Ontario--(Newsfile Corp. - June 26, 2026) - ScaleHealth.ca activates its Branded Clinical Hub model, giving health & wellness brands an instant, co-branded recovery access layer without infrastructure, hiring, or compliance overhead. Now live with DR-HO's existing traffic: providing virtual assessments, product education, partner services & incremental revenue, with zero clinical build required. Brands route
2026-06-26 4:08 PM EDT | Scale Health Network Inc.
Hemostemix Closes $360,000 First Tranche of Private Placement
Calgary, Alberta--(Newsfile Corp. - June 26, 2026) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is pleased to announce it has closed the first tranche of its previously announced non-brokered private placement of units (the "Offering"), as originally disclosed on June 17, 2026. The Company raised aggregate gross proceeds of CDN$360,000 under the first tranche through the issuance of 7,200,000 units ("Units") at
Biotechnologies, Pharmaceutique, Santé
2026-06-26 8:47 AM EDT | Hemostemix Inc.
Charlotte's Web Provides Update on Diverging Hemp Policies: Federal Momentum Builds as California Restricts Therapeutic Hemp Product Access
Louisville, Colorado--(Newsfile Corp. - June 26, 2026) - Charlotte's Web Holdings, Inc. (TSX: CWEB) (OTCQX: CWBHF) ("Charlotte's Web" or the "Company"), a botanical wellness innovation company and a market leader in hemp wellness, today provided an update on developments pulling federal and state hemp policy in opposite directions. California restriction effective July 1, 2026 New California requirements under SB 378 and related state regulations will sig
2026-06-26 7:21 AM EDT | Charlotte's Web Holdings, Inc.
QScreen AI Announces Adoption of Semi-Annual Reporting
Toronto, Ontario--(Newsfile Corp. - June 26, 2026) - QScreen AI Inc. (CSE: QAI) (OTC Pink: PMEDF) (FSE: 3QP) ("QScreen" or "QAI"), an innovator in physiological AI screening, intelligence platform for clinical and occupational health applications, announces that it has elected to voluntarily adopt semi-annual financial reporting and rely on the exemptions in Coordinated Blanket Order 51-933 - Exemptions to Permit Semi-Annual Reporting for Certain Venture Issuers ("CBO 51-933"). Introduc
2026-06-26 7:02 AM EDT | QScreen AI Inc.
Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series
King of Prussia, Pennsylvania--(Newsfile Corp. - June 26, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio Pharmaceuticals announced today that Robert Bitterman, CEO and Chairman of the Board, will present an overview of the Company's INTASYL® siRNA platform, including its lead clinical candidate PH-762
Biotechnologies, Soins de santé et hôpitaux, Pharmaceutique, Santé
2026-06-26 7:00 AM EDT | Phio Pharmaceuticals Corp.
Medexus Announces Fiscal Year 2026 Results, Demonstrating Continued Momentum and Strong Product-Level Performance of GRAFAPEX (treosulfan) for Injection
Ontario and Chicago, Illinois--(Newsfile Corp. - June 25, 2026) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) today announced its operating and financial results and provided a business update for the company's fourth fiscal quarter and fiscal year ended March 31, 2026 (the company's fiscal Q4 2026 and fiscal year 2026). All dollar amounts in this news release are in US dollars unless specified otherwise. Company overview Medexus is currently focused on deliv
Biotechnologies, Soins de santé et hôpitaux, Pharmaceutique, Santé
2026-06-25 6:00 PM EDT | Medexus Pharmaceuticals Inc.
Mobile-health Network Solutions Announces Effective Date of Reverse Stock Split
Singapore, Singapore--(Newsfile Corp. - June 25, 2026) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or the "Company"), a leading AI-powered digital health platform, today announced a one-for-six reverse stock split (the "Reverse Stock Split") of the Company's Class A Ordinary Shares ("Class A Ordinary Shares") will become effective at 12:01 a.m. Eastern Time on Monday, June 29, 2026. The Class A Ordinary Shares will continue to trade under its ex
2026-06-25 9:00 AM EDT | Mobile-health Network Solutions